M.E.G. Naranjo

664 total citations
12 papers, 425 citations indexed

About

M.E.G. Naranjo is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, M.E.G. Naranjo has authored 12 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in M.E.G. Naranjo's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). M.E.G. Naranjo is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). M.E.G. Naranjo collaborates with scholars based in Spain, Mexico and Brazil. M.E.G. Naranjo's co-authors include Adrián LLerena, Eva Peñas‐Lledó, Fernanda Rodrigues‐Soares, Fernando de Andrés, Humberto Fariñas, Eduardo Tarazona‐Santos, Ingrid Fricke-Galindo, Marisol López, Blanca Patricia Lazalde-Ramos and Martha Sosa‐Macías and has published in prestigious journals such as Journal of Psychiatric Research, Expert Opinion on Drug Metabolism & Toxicology and Pharmacogenomics.

In The Last Decade

M.E.G. Naranjo

12 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.E.G. Naranjo Spain 10 305 114 76 67 55 12 425
Katarzyna Drozda United States 11 337 1.1× 52 0.5× 110 1.4× 63 0.9× 66 1.2× 16 440
D. A. Flockhart United States 9 283 0.9× 132 1.2× 92 1.2× 68 1.0× 84 1.5× 20 554
Wim J. Tamminga Netherlands 10 264 0.9× 105 0.9× 85 1.1× 88 1.3× 60 1.1× 13 492
Humberto Fariñas Spain 10 217 0.7× 81 0.7× 67 0.9× 42 0.6× 44 0.8× 17 345
Sung Eun Sim South Korea 6 321 1.1× 136 1.2× 70 0.9× 168 2.5× 68 1.2× 19 657
Gina Mejía‐Abril Spain 15 259 0.8× 108 0.9× 128 1.7× 69 1.0× 123 2.2× 49 647
Chandrasekaran Adithan India 14 154 0.5× 81 0.7× 75 1.0× 55 0.8× 82 1.5× 27 597
Jean Dinh United States 8 253 0.8× 68 0.6× 140 1.8× 62 0.9× 69 1.3× 20 409
Evan T. Ogburn United States 11 197 0.6× 116 1.0× 86 1.1× 126 1.9× 88 1.6× 11 567
Leif Bertilsson Sweden 8 327 1.1× 134 1.2× 59 0.8× 101 1.5× 135 2.5× 9 500

Countries citing papers authored by M.E.G. Naranjo

Since Specialization
Citations

This map shows the geographic impact of M.E.G. Naranjo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.E.G. Naranjo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.E.G. Naranjo more than expected).

Fields of papers citing papers by M.E.G. Naranjo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.E.G. Naranjo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.E.G. Naranjo. The network helps show where M.E.G. Naranjo may publish in the future.

Co-authorship network of co-authors of M.E.G. Naranjo

This figure shows the co-authorship network connecting the top 25 collaborators of M.E.G. Naranjo. A scholar is included among the top collaborators of M.E.G. Naranjo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.E.G. Naranjo. M.E.G. Naranjo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Dorado, Pedro, et al.. (2017). Lessons from Cuba for Global Precision Medicine: CYP2D6 Genotype Is Not a Robust Predictor of CYP2D6 Ultrarapid Metabolism. OMICS A Journal of Integrative Biology. 21(1). 17–26. 19 indexed citations
2.
Moya, Graciela, et al.. (2016). High frequency of CYP2D6 ultrarapid metabolizer genotypes in an Ashkenazi Jewish population from Argentina. The Pharmacogenomics Journal. 17(4). 378–381. 8 indexed citations
3.
Naranjo, M.E.G., et al.. (2016). High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studies. The Pharmacogenomics Journal. 16(5). 485–490. 23 indexed citations
4.
Fricke-Galindo, Ingrid, M.E.G. Naranjo, Fernanda Rodrigues‐Soares, et al.. (2015). Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes. Expert Opinion on Drug Metabolism & Toxicology. 11(12). 1893–1905. 47 indexed citations
5.
Fricke-Galindo, Ingrid, Fernanda Rodrigues‐Soares, M.E.G. Naranjo, et al.. (2015). Interethnic variation of CYP2C19 alleles, ‘predicted’ phenotypes and ‘measured’ metabolic phenotypes across world populations. The Pharmacogenomics Journal. 16(2). 113–123. 120 indexed citations
6.
Peñas‐Lledó, Eva, Sébastien Guillaume, M.E.G. Naranjo, et al.. (2014). A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances. The Pharmacogenomics Journal. 15(2). 172–176. 22 indexed citations
7.
LLerena, Adrián, M.E.G. Naranjo, Fernanda Rodrigues‐Soares, et al.. (2014). Interethnic variability ofCYP2D6alleles and of predicted and measured metabolic phenotypes across world populations. Expert Opinion on Drug Metabolism & Toxicology. 10(11). 1569–1583. 121 indexed citations
8.
Peñas‐Lledó, Eva, Sébastien Guillaume, M.E.G. Naranjo, et al.. (2014). ABCB1 gene polymorphisms and violent suicide attempt among survivors. Journal of Psychiatric Research. 61. 52–56. 13 indexed citations
9.
Lazalde-Ramos, Blanca Patricia, Margarita L. Martínez‐Fierro, Carlos Galaviz‐Hernández, et al.. (2014). CYP2D6Gene Polymorphisms and Predicted Phenotypes in Eight Indigenous Groups from Northwestern Mexico. Pharmacogenomics. 15(3). 339–348. 24 indexed citations
10.
Andrés, Fernando de, Martha Sosa‐Macías, Blanca Patricia Lazalde-Ramos, et al.. (2013). Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: the CEIBA cocktail. Drug metabolism and drug interactions. 28(3). 135–146. 14 indexed citations
11.
Ribeiro, Carolina, et al.. (2013). Characterization of CYP2D6 genotypes and metabolic profiles in the Portuguese population: pharmacogenetic implications. Personalized Medicine. 10(7). 709–718. 10 indexed citations
12.
Dorado, Pedro, Fernando de Andrés, M.E.G. Naranjo, et al.. (2012). High-performance liquid chromatography method using ultraviolet detection for the quantification of aripiprazole and dehydroaripiprazole in psychiatric patients. Drug metabolism and drug interactions. 27(3). 165–170. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026